Akari Therapeutics Plc - ADR
Exchange: IEX Type: American Depository Receipt
Price at Close
Change:
Volume:
×
Buy American Depository Receipt
Remote Buying of Akari Therapeutics Plc - ADR through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell American Depository Receipt
Remote Selling of Akari Therapeutics Plc - ADR through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Entrada Therapeutics Seeks $150 Million U.S. IPO via Seeking Alpha
Seres Therapeutics Inc (MCRB): Price Now Near $6.21; Daily Chart Shows Downtrend on 100 Day Basis via ETF Daily News
: Jasper Therapeutics started at outperform with $19 stock price target at BMO Capital via MarketWatch
Esperion Therapeutics to reduce workforce by 40% via Yahoo Finance
Akari Therapeutics Plc - ADR Performance
Active Alerts for IEX:AKTX
You don't have any alerts set for IEX:AKTX.
About Akari Therapeutics Plc - ADR
Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.
Real-time AKTX to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.